Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998052556) GLUCOSAMINE FATTY ACID COMPOSITIONS AND THEIR USE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052556 International Application No.: PCT/GB1998/001425
Publication Date: 26.11.1998 International Filing Date: 18.05.1998
Chapter 2 Demand Filed: 14.12.1998
IPC:
A61K 31/205 (2006.01) ,A61K 31/70 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
205
Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
Applicants:
SCOTIA HOLDINGS PLC [GB/GB]; Weyvern House Weyvern Park Portsmouth Road Peasmarsh Guildford, Surrey GU3 1NA, GB (AllExceptUS)
HORROBIN, David, Frederick [GB/GB]; GB (UsOnly)
MANKU, Mehar, Singh [GB/GB]; GB (UsOnly)
McMORDIE, Austin [GB/GB]; GB (UsOnly)
Inventors:
HORROBIN, David, Frederick; GB
MANKU, Mehar, Singh; GB
McMORDIE, Austin; GB
Agent:
FARWELL, William, Robert; Phillips & Leigh 7 Staple Inn Holborn London WC1V 7QF, GB
Priority Data:
9710351.920.05.1997GB
Title (EN) GLUCOSAMINE FATTY ACID COMPOSITIONS AND THEIR USE
(FR) COMPOSITIONS DE GLUCOSAMINE ET D'ACIDE GRAS ET LEUR UTILISATION
Abstract:
(EN) Compositions of glucosamine and an essential fatty acid, especially one or more of the 'delta-6-desaturated' n-6 and n-3 essential fatty acids such as GLA, DGLA, SA, EPA, and DHA, other than compositions comprising chondroitin sulphate; and their use in inflammatory joint conditions including osteoarhitis and arthritis.
(FR) On décrit des compositions de glucosamine et d'un acide gras essentiel, en particulier un ou plusieurs des acides gras essentiels n-6 et n-3 'delta-6-désaturés', tels que GLA, DGLA, SA, EPA et DHA, mais différentes des compositions à base de sulphate de chondroïtine.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0977561CA2290488AU1998074423MYPI 98002241